Katana Labs is a German DeepTech and AI startup, founded in 2023.

We combine extensive expertise in software engineering, AI model development, clinical science, oncology, digital pathology, and business. United by one mission, making chronic and complex diseases curable, we believe that first, we must improve our understanding of biology by several orders of magnitude. To achieve that, we leverage cutting-edge software and pioneering AI technologies to empower subject matter experts, like researchers and clinical scientists, in their quest to decode biology. Supported by experienced investors, business angels, and advisors, we are committed to provide AI-enhanced tools that help realize the promises of precision medicine for everyone.

---

Katana Labs is co-financed by the European Union, from tax revenues on the basis of the budget adopted by the Saxon State Parliament, by Sächsische Aufbaubank (SAB) and by Technologiegründerfonds Sachsen (TGFS) via the TGFS Basic fund. Katana Labs is also member of Biosaxony via leap:up accelerator: